A Qualitative Study to Explore Patient Perspectives of Prophylactic Treatment with OnabotulinumtoxinA for Chronic Migraine
Crossref DOI link: https://doi.org/10.1007/s40122-021-00316-2
Published Online: 2021-09-14
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilderman, Igor http://orcid.org/0000-0003-0499-2791
Tallarigo, Deborah
Pugacheva-Zingerman, Olga
Funding for this research was provided by:
AbbVie (Publication Grant)
Text and Data Mining valid from 2021-09-14
Version of Record valid from 2021-09-14
Article History
Received: 5 August 2021
Accepted: 1 September 2021
First Online: 14 September 2021